Allogeneic stem cell transplantation for thalassemia major in India
Allogeneic stem cell transplantation (allo-SCT) is the only currently available curative treatment for thalassemia major. Since it was first done in 1981, several thousand patients have benefited from it and it is now possible to offer this treatment in different parts of the world with good results...
Main Authors: | Vikram Mathews, Poonkuzhali Balasubramanian, Aby Abraham, Biju George, Alok Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Pediatric Hematology Oncology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468124517300979 |
Similar Items
-
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial
by: Lorenzo Lazzari, et al.
Published: (2021-09-01) -
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update
by: Xiao-hui Zhang, et al.
Published: (2021-09-01) -
Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplantation
by: Betul Tavil
Published: (2014-02-01) -
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
by: Lanping Xu, et al.
Published: (2018-03-01) -
The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia
by: Mattia Algeri, et al.
Published: (2021-08-01)